# Broccoli Sprout Extract in Treating Patients With Breast Cancer

> **NCT01753908** · EARLY_PHASE1 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 30 (actual)

## Conditions studied

- Ductal Breast Carcinoma
- Ductal Breast Carcinoma In Situ
- Estrogen Receptor Negative
- Estrogen Receptor Positive
- Invasive Breast Carcinoma
- Lobular Breast Carcinoma
- Postmenopausal
- Stage IA Breast Cancer
- Stage IB Breast Cancer
- Stage IIA Breast Cancer
- Stage IIB Breast Cancer

## Interventions

- **DRUG:** Broccoli Sprout Extract
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Pharmacological Study
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01753908
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-21
- **Primary completion:** 2018-07-23
- **Final completion:** 2018-08-23
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01753908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01753908, "Broccoli Sprout Extract in Treating Patients With Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01753908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*